Search
for
Sort by
Research 30 of 48
- Clinical perspective on management of key adverse events with sacituzumab govitecan
- 3P's (Pharmacokinetic, Pharmacodynamic, and Pharmacogenomic) of Valproate: What's New?
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Evaluation of Personalized Skincare Through in-silico Gene Interactive Networks and Cellular Responses to UVR and Oxidative Stress
- The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
- Role of skin enzymes in metabolism of topical drugs
- The Rotterdam Study: 2018 update on objectives, design and main results
- The Rotterdam Study: 2016 objectives and design update
- Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations
- Bioavailability File: Bicalutamide
- Testicular Steroidogenesis
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
- EtG Quantification in Hair and Different Reference Cut-Offs in Relation to Various Pathologies: A Scoping Review
- Flavonoids and saponins: What have we got or missed?
- Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- The Rotterdam Study: objectives and design update
- Intracrine androgen biosynthesis, metabolism and action revisited
- Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug–drug interactions
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Is dehydroepiandrosterone a hormone?
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Cloning, computational analysis and expression profiling of steroid 5 alpha-reductase 1 (SRD5A1) gene during reproductive phases and ovatide stimulation in endangered catfish, Clarias magur
- Ritlecitinib: First Approval